Multiple Sclerosis Pipeline, FDA Approvals, Clinical Trials Development and Companies 2023

Retrieved on: 2023-12-07 00:17:05

Tags for this article:

Multiple sclerosis

Biogen

Management of multiple sclerosis

Fingolimod

Bristol-Myers Squibb

Genentech

Multiple sclerosis research

Click the tags to see associated articles and topics

Multiple Sclerosis Pipeline, FDA Approvals, Clinical Trials Development and Companies 2023. View article details on hiswai:

Excerpt

... Biotechnology, Merck Serono, CinnaGen, Immune Response BioPharma, Inc., Clene Nanomedicine, GeNeuro SA, Sanofi, Bristol-Myers Squibb, HuniLife ...

Article found on: www.digitaljournal.com

View Original Article